PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-53

  1. 1,664 Posts.
    lightbulb Created with Sketch. 177
    To add to that, to give PR his due, he has not
    succumbed to low ball offers from BP, but as
    the pressure builds to raise substantial finance,
    I am concerned he may cave in.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.